Reducing the risk of endophthalmitis

被引：1
|
作者：
Mamalis, Nick [1 ]
机构：
[1] Univ Utah, John A Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT USA
来源：
JOURNAL OF CATARACT AND REFRACTIVE SURGERY | 2019年 / 45卷 / 09期
关键词：
PROPHYLAXIS;
D O I：
10.1016/j.jcrs.2019.07.025
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：1217 / 1218
页数：2
相关论文
共 50 条
  • [1] Reducing the risk of postoperative endophthalmitis
    Olson, RJ
    SURVEY OF OPHTHALMOLOGY, 2004, 49 : S55 - S61
  • [2] Reducing the Risk of Endophthalmitis After Intravitreous Injection
    Kim, Stephen J.
    Chomsky, Amy S.
    Sternberg, Paul, Jr.
    JAMA OPHTHALMOLOGY, 2013, 131 (05) : 674 - 675
  • [3] Reducing the risk of endophthalmitis after cataract surgery
    Chang, David F.
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (12): : 2008 - 2009
  • [4] Reducing the risk of endophthalmitis following intravitreal injections
    Scott, Ingrid U.
    Flynn, Harry W., Jr.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2007, 27 (01): : 10 - 12
  • [5] Reducing the risk of endophthalmitis after cataract surgery - Reply
    Ng, Jonathon Q.
    Morlet, Nigel
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 2007, 33 (12): : 2009 - 2009
  • [6] Reducing endophthalmitis risk factors: Where we stand
    Holz, ER
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (06) : 1097 - 1098
  • [7] Reducing endophthalmitis in India: An example of the importance of critical appraisal
    Thomas, Ravi
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2010, 58 (06) : 560 - U117
  • [8] Repackaged bevacizumab: no increased risk of endophthalmitis
    Reactions Weekly, 2015, 1566 (1) : 9 - 9
  • [9] Intraocular lens implants and risk of endophthalmitis
    Garzozi, HJ
    Harris, A
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (05) : 554 - 554
  • [10] Risk factors for enucleation or evisceration in endophthalmitis
    Ahmad, Meleha
    Parikh, Rupin
    Akhlaq, Anam
    Pradeep, Tejus
    Breazzano, Mark P.
    Fu, Roxana
    ORBIT-THE INTERNATIONAL JOURNAL ON ORBITAL DISORDERS-OCULOPLASTIC AND LACRIMAL SURGERY, 2023, 42 (03): : 279 - 289
12345